Kallikrein Enteric-coated Tablets

It has the effects of dilating blood vessels and improving microcirculation; activating plasmin and reducing blood viscosity; activating phospholipase A2, preventing platelet aggregation, and preventing thrombosis.

The main ingredient of this product is pancreatic kallikreinogenase.

This product is an enteric-coated tablet, which is off-white or light brown in color after removing the coating.

Vasodilator. It improves microcirculation. It is mainly used for microcirculatory disorders, such as nephropathy caused by diabetes, peripheral neuropathy, retinopathy, fundus disease and ischemic cerebrovascular disease. It can also be used as an auxiliary treatment for hypertension.

Take orally 120-240 units at a time (2-4 tablets at a time), 360-720 units per day (three times a day), on an empty stomach.

Occasionally, there may be allergic reactions such as rash, itching, stomach discomfort, and fatigue, which disappear after stopping the medication.

It is contraindicated in the acute phase of cerebral hemorrhage and other hemorrhagic diseases.

Precautions for children: This experiment has not been conducted and there is no reliable reference. Precautions for pregnancy and lactation: Not yet clear. Precautions for the elderly: This experiment has not been conducted and there is no reliable reference.

1. This product cannot be used simultaneously with protease inhibitors. 2. This product has a synergistic effect with angiotensin converting enzyme inhibitors (ACEI).

Keep tightly closed in a cool, dry place.

60 units

18 months.

Changzhou Qianhong Biopharma Co., Ltd.

• Founded in:

  2003-04-30

• Address:

  No. 518, Yunhe Road, Xinbei District, Changzhou

• Tax NO.:

  91320400748726864T

• Registered Funds:

  1,279.8 million yuan

• Website:

  Log in to view

• Email:

  Log in to view